All ETFs

LYFAX

ETF

LYFAX · UNKNOWN · 60 holdings

16,03 €

▲ 0,21 € (1,33%)

Day Range

—

52-Week Range

—

Volume

—

Ouverture —

Moyenne 50J / 200J

—

Moyenne 50J / 200J

—

About LYFAX

No description available for this ETF.

Fund Details

Expense Ratio: —
Inception Date: —
Prev. Close: 15,82 €
Exchange: UNKNOWN
Currency: USD
Holdings As Of: Apr 10, 2026
Tracked Holdings: 83.3%
HHI Score: 258,40
Top Sector: Healthcare (78.496653%)

Performance

Moderate (23,8%) ↗ Accelerating

▲ 1,89%

▲ 1,38%

▲ 2,93%

▲ 20,96%

YTD

▲ 2,28%

▲ 35,80%

▲ 21,69%

1W return (+1.89%) exceeds 1M (+1.38%) — momentum is building

Price History

Concentration Risk

41,03% Moderately Concentrated

Diversified Concentrated

The top 10 holdings represent 41,03% of the fund. A moderate concentration level — the fund balances top holdings with broader diversification.

Top Holdings Today

Weighted by position size

GILD

▼ -2,18%

VRTX

▼ -2,34%

IONS

▼ -1,65%

INCY

▼ -0,92%

INSM

▼ -3,00%

ARGX

▼ -0,11%

AXSM

▼ -0,44%

NBIX

▼ -2,09%

ROIV

▼ -0,96%

Weighted avg. of top holdings ▼ -1,67%

Sector Allocation

Healthcare

78,50%

Top 10 Holdings

41,03% of fund

GILD Gilead Sciences Inc.

7,21%

VRTX Vertex Pharmaceuticals Incorporated

5,71%

AstraZeneca PLC AstraZeneca PLC

5,28%

IONS Ionis Pharmaceuticals, Inc.

3,96%

INCY Incyte Corporation.

3,59%

INSM Insmed Inc

3,57%

ARGX Argenx SE

3,24%

AXSM Axsome Therapeutics Inc.

3,00%

NBIX Neurocrine Biosciences Inc

2,83%

ROIV Roivant Sciences Ltd

2,64%

Other positions

6,38%

All Holdings (60)

Top 10: 41,03% of fund

#	Ticker	Name	Weight	Shares	Market Value
1	GILD	Gilead Sciences Inc.	7,21%	21 761	2,67 M
2	VRTX	Vertex Pharmaceuticals Incorporated	5,71%	4 663	2,11 M
3	AstraZeneca PLC	AstraZeneca PLC	5,28%	21 243	1,95 M
4	IONS	Ionis Pharmaceuticals, Inc.	3,96%	18 523	1,47 M
5	INCY	Incyte Corporation.	3,59%	13 471	1,33 M
6	INSM	Insmed Inc	3,57%	7 588	1,32 M
7	ARGX	Argenx SE	3,24%	1 425	1,20 M
8	AXSM	Axsome Therapeutics Inc.	3,00%	6 088	1,11 M
9	NBIX	Neurocrine Biosciences Inc	2,83%	7 383	1,05 M
10	ROIV	Roivant Sciences Ltd	2,64%	45 076	978 149,2
11	Avadel Pharmaceutica	Avadel Pharmaceuticals PLC	2,19%	37 693	812 284,15
12	Apogee Therapeutics	Apogee Therapeutics Inc.	2,19%	10 751	811 485,48
13	EXAS	Exact Sciences Corporation	2,17%	7 901	802 425,56
14	PTGX	Protagonist Therapeutics Inc	2,02%	8 549	746 669,66
15	AMGN	Amgen Inc.	1,95%	2 202	720 736,62
16	ASND	Ascendis Pharma A/S	1,87%	3 238	690 471,12
17	ABBV	AbbVie Inc.	1,84%	2 979	680 671,71
18	SNY	Sanofi SA	1,78%	13 594	658 765,24
19	BIIB	Biogen Inc	1,72%	3 627	638 315,73
20	JAZZ	Jazz Pharmaceuticals PLC	1,55%	3 368	572 560,0
21	RYTM	Rhythm Pharmaceuticals Inc	1,46%	5 052	540 766,08
22	ALNY	Alnylam Pharmaceuticals Inc.	1,39%	1 295	514 956,75
23	CPRX	Catalyst Pharmaceuticals Inc.	1,39%	22 020	513 946,8
24	BNTX	BioNTech SE	1,37%	5 311	505 607,2
25	Avidity Biosciences	Avidity Biosciences Inc.	1,36%	6 995	504 549,35
26	NewAmsterdam Pharma	NewAmsterdam Pharma Company NV	1,30%	13 731	481 683,48
27	WVE	Wave Life Sciences Ltd.	1,27%	27 590	469 030,0
28	KRYS	Krystal Biotech Inc	1,21%	1 813	446 977,02
29	NUVL	Nuvalent Inc	1,20%	4 404	442 998,36
30	SRRK	Scholar Rock Holding Corp.	1,19%	9 974	439 354,7
31	KYMR	Kymera Therapeutics Inc	1,06%	5 035	391 773,35
32	PSNL	Personalis Inc	1,03%	47 796	380 456,16
33	EWTX	Edgewise Therapeutics Inc.	0,99%	14 703	364 854,95
34	AGIO	Agios Pharmaceuticals Inc	0,97%	13 141	357 698,02
35	NRIX	Nurix Therapeutics Inc.	0,93%	18 134	344 001,98
36	ADMA	Adma Biologics Inc	0,93%	18 782	342 583,68
37	XERS	Xeris Biopharma Holdings Inc	0,92%	43 392	340 627,2
38	CYTK	Cytokinetics Inc	0,91%	5 311	337 460,94
39	ORKA	Oruka Therapeutics Inc	0,89%	10 880	329 772,8
40	HALO	Halozyme Therapeutics Inc	0,82%	4 533	305 070,9
41	Disc Medicine Inc	Disc Medicine Inc	0,81%	3 756	298 263,96
42	NTRA	Natera Inc.	0,80%	1 295	296 671,55
43	TRVI	Trevi Therapeutics Inc	0,77%	22 667	283 790,84
44	MDXHealth SA	MDXHealth SA	0,72%	75 126	268 199,82
45	DAWN	Day One Biopharmaceuticals Inc.	0,68%	26 812	249 887,84
46	ICLR	Icon PLC	0,64%	1 295	235 974,9
47	ABUS	Arbutus Biopharma Corp.	0,62%	47 925	230 519,25
48	MGTX	MeiraGTx Holdings PLC	0,61%	28 496	226 543,2
49	CGEM	Cullinan Therapeutics Inc	0,53%	19 041	197 074,35
50	DSGN	Design Therapeutics Inc.	0,51%	20 262	190 057,56
51	AORT	Artivion Inc	0,49%	4 015	183 124,15
52	RAPP	Rapport Therapeutics Inc	0,49%	6 030	182 950,2
53	Aldeyra Therapeutics	Aldeyra Therapeutics Inc	0,49%	34 912	180 844,16
54	IQV	IQVIA Holdings Inc.	0,47%	777	175 143,57
55	Rezolute Inc	Rezolute Inc	0,43%	67 056	158 252,16
56	ARVN	Arvinas Inc	0,40%	12 435	147 479,1
57	TECX	Tectonic Therapeutic Inc	0,36%	6 476	135 089,36
58	Black Diamond Therap	Black Diamond Therapeutics Inc	0,35%	53 625	130 308,75
59	SION	Sionna Therapeutics Inc.	0,30%	2 720	111 900,8
60	NTLA	Intellia Therapeutics Inc	0,26%	10 880	97 811,2

Showing top 10 of 60 holdings · Listed: 93,62% · 6,38% in other positions

Related ETFs